Petros Grivas/fredhutch.org
Feb 13, 2025, 09:30
Petros Grivas: TROPiCS04 P3 trial data has been published
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared an article he and his colleagues authored on X:
“We just published TROPiCS04 P3 trial data
Annals of Oncology with Tom Powles, Y. Loriot, Scott Tagawa et al.
Primary OS endpoint was not met, higher ORR with SG (23%) vs taxane/vinflunine (14%), G-CSF primary prophy only ~20% ->G5 neutropenic events on SG.”
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial
Authors: Tom Powles et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 10, 2025, 18:19
Jun 10, 2025, 17:40
Jun 10, 2025, 17:36